Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma

R. S. Stern, K. T. Nichols, E. Bauer, J. Koo, J. H. Epstein, J. Wolf, T. P. Nigra, J. Voorhees, T. F. Anderson, J. Prystowsky, S. Muller, M. McEvoy, J. R. Taylor, N. Zaias, F. Urbach, K. A. Arndt, R. D. Baughman, I. M. Braverman, J. Murray, V. WerthA. Sober

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

A child was treated from age 18 months to 8 years with oral methoxsalen and ultraviolet A radiation (PUVA) for refractory psoriasis. Two basal cell cancers developed before age 21 years, suggesting that exposure to PUVA in childhood increases the risk of basal cell cancer.

Original languageEnglish
Pages (from-to)915-917
Number of pages3
JournalJournal of Pediatrics
Volume129
Issue number6
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Dive into the research topics of 'Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma'. Together they form a unique fingerprint.

Cite this